Simple Summary Epithelial ovarian cancer is one of the most lethal cancers in women and is
typically diagnosed at an advanced-stage. Historically, primary tumor reductive surgery was …

Primary debulking surgery (PDS) has remained the only treatment of ovarian cancer with
survival advantage since its development in the 1970s. However, survival advantage is only …

Importance Randomized clinical trials examining the effectiveness of neoadjuvant
chemotherapy (NACT) for advanced ovarian cancer predominantly included patients with …

Background Ovarian cancer (OC) is the most common malignant neoplasm of the female
reproductive system in developed countries. Early detection, diagnosis and prognosis are …

Simple Summary Cytoreductive surgery represents the cornerstone of the management of
advanced epithelial ovarian cancers (aEOC). Currently, two alternative strategies coexist …

Introduction High-grade serous ovarian cancer (HGSOC) is the second most frequent
gynecological malignancy but the most lethal, partially due to the spread of the disease …

Abstract Purpose of Review Summarize the writings published in the last 5 years on the
management of surgery in the first line of treatment for advanced ovarian cancer. Recent …

This study aimed to investigate the cytotoxicity of a cluster of differentiation 70 antibody‐drug
conjugate (CD70‐ADC) against ovarian cancer in in vitro and in vivo xenograft models …

Objective To examine population-level trends, characteristics, and outcomes of patients with
stage IVB endometrial cancer who received neoadjuvant chemotherapy (NACT) prior to …

Female infertility is a significant health issue worldwide with a rising incidence. Anti-cancer
therapy is one of the most important reasons for increasing infertility. Although anti-cancer …